Showing results (231-240 of 1,297) with videos related to

Sort By:
Pageof 130
Diabetes Care|June 20, 2022
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS)Ele Ferrannini, Simona Baldi, Tiziana Scozzaro, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 26, 2020
Higher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKDFlory T Muanda, Matthew A Weir, Lavanya Bathini, et al.
Circulation|November 15, 2017
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)Kenneth W Mahaffey, Bruce Neal, Vlado Perkovic, et al.
The Cochrane Database of Systematic Reviews|March 2, 2013
Antiplatelet agents for chronic kidney diseaseSuetonia C Palmer, Lucia Di Micco, Mona Razavian, et al.
Kidney International Reports|January 16, 2026
Iptacopan in Patients With IgA Nephropathy From East AsiaHong Zhang, Vlado Perkovic, Jonathan Barratt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 8, 2015
The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic reviewRachael Lisa Morton, Iryna Schlackow, Borislava Mihaylova, et al.
Internal Medicine Journal|December 22, 2025
Haemodialysis catheter utilisation and factors associated with catheter-related bloodstream infection in Aotearoa New Zealand: Report from the binational, prospective, cluster-randomised trialJayson Catiwa, Sradha Kotwal, Martin Gallagher, et al.
Diabetes Care|August 9, 2015
Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetesMerlin C Thomas, Mark Woodward, Bruce Neal, et al.
Journal of the American Heart Association|January 15, 2013
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitusGraham S Hillis, Jun Hata, Mark Woodward, et al.
The Lancet. Diabetes & Endocrinology|June 26, 2018
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trialsVlado Perkovic, Dick de Zeeuw, Kenneth W Mahaffey, et al.
Pageof 130